Physician profile
Fareed Kannout
NPI 1144242892
$2,261.52
in general payments reported to CMS, 2019-2025
20 companies · $777 in 2025
The $777 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $117 · 2021: $378 · 2022: $137 · 2023: $222 · 2024: $472 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.82 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $737.63 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $561.78 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $257.68 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $127.08 | 2021-2023 | Trelegy Ellipta |
| Pfizer INC. | $83.30 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.80 | 2021-2024 | |
| Abbott Laboratories | $63.42 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Janssen Pharmaceuticals, INC | $60.27 | 2019-2022 | |
| Exact Sciences Corporation | $52.12 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $40.10 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.99 | 2019 | |
| Lilly USA, LLC | $32.99 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.41 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $24.80 | 2021 | |
| Inari Medical, INC. | $21.14 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $15.29 | 2021 | |
| Hologic Sales and Service, LLC | $14.71 | 2024 | Aptima, Thinprep 2000 Processor |
| Genentech USA, INC. | $13.13 | 2020 | |
| Zyla Life Sciences, INC. | $12.71 | 2019 | |
| Horizon Therapeutics Plc | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fareed Kannout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.